CDSCO UID MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd

AMYLASE TEST KIT(LIQUIZYME α AMYLASE )

Name: AMYLASE TEST KIT(LIQUIZYME α AMYLASE ) — CDSCO UID MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd
Creator: Beacon Diagnostics Pvt. Ltd.
Keywords: AMYLASE TEST KIT(LIQUIZYME α AMYLASE ), MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd, SEROCON CYSTATIN C CONTROL SET, Device Class Class B, Beacon Diagnostics Pvt. Ltd., CDSCO registration

Beacon Diagnostics Pvt. Ltd.Device Class Class BIndia CDSCOBrand: SEROCON CYSTATIN C CONTROL SET

VerifiedCDSCO · official registry

Registration details

UID: MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd
Device class: Class B
Brand name: SEROCON CYSTATIN C CONTROL SET
License holder: Beacon Diagnostics Pvt. Ltd.
Approving authority: Gujarat
Product information: For the quantitative determination of alpha-Amylase in human serum, plasma and urine

About this record

AMYLASE TEST KIT(LIQUIZYME α AMYLASE ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd. This device is marketed under the brand name SEROCON CYSTATIN C CONTROL SET. The license holder is Beacon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.